Login / Signup

We have had a gutful: The need for deprescribing proton pump inhibitors.

M NauntonG M PetersonLouise S DeeksH YoungS Kosari
Published in: Journal of clinical pharmacy and therapeutics (2017)
Proton pump inhibitors continue to be overused worldwide and should be a focus for deprescribing programmes. Ongoing education and awareness campaigns for health professionals and patients, including electronic reminders at the point of prescribing, are strategies that have potential to reduce PPI use in individuals who do not have an evidence-based clinical indication for their long-term use.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • primary care
  • ejection fraction
  • healthcare
  • prognostic factors
  • emergency department
  • risk assessment
  • patient reported outcomes
  • small molecule
  • drug induced